Publications

Avelumab First-Line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the Javelin Bladder 100 Phase 3 Trial

AuthID
P-00Y-BVZ

Author(s)

Grivas, P

Park, SH

Voog, E

Caserta, C

Gurney, H

Bellmunt, J

Kalofonos, H

Ullen, A

Loriot, Y

Sridhar, SS

Yamamoto, Y

Petrylak, DP

Sternberg, CN

Gupta, S

Huang, B

Costa, N

Laliberte, RJ

di Pietro, A

Valderrama, BP

Powles, T

Document Type

Article

Year published

2023

Published

in EUROPEAN UROLOGY, ISSN: 0302-2838

Volume: 84, Issue: 1, Pages: 95-108 (14)

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/j.eururo.2023.03.030

Pubmed: 37121850

Scopus: 2-s2.0-85153942855

Wos: WOS:001028248100001

Source Identifiers

ISSN: 0302-2838

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Avelumab First-Line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the Javelin Bladder 100 Phase 3 Trial

Useful Links

Get Help

Federated Authentication (Click on the image)

Avelumab First-Line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the Javelin Bladder 100 Phase 3 Trial

Useful Links

Get Help